Vertex Pharmaceuticals (VRTX)

Hold Recap: Q2 2026

Vertex Raises Revenue, Not Earnings, and Buys a Fifth Pillar That Does Not Pay Until 2029

Hold Recap: Q1 2026

The Switch Works, the Launches Slip: Initiating Vertex at Hold on a Guide That Turns 8% Revenue Growth Into 3% EPS Growth